Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ty800 Vaccine in Healthy Adults
NCT00498654Phase 2Completed
- Sponsor
- Avant Immunotherapeutics, Inc.
- Start
- Jul 2007
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Ty800 in typhoid fever, sponsored by Avant Immunotherapeutics, Inc.. Started Jul 2007; status: completed.
02
Drugs
Ty800
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT00498654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00498654.